Table 1.
Number of drugs and active ingredients among statins*
| Year | 2005 | 2006 | 2007 | 2008 | 2009 | |
|---|---|---|---|---|---|---|
| Number of drugs |
Total |
183 |
207 |
217 |
227 |
271 |
|
Core medicines (A) |
|
167 |
192 |
176 |
204 |
|
|
Exiting medicines (B) |
|
16 |
15 |
41 |
23 |
|
|
New entrants (C) |
|
40 |
25 |
51 |
67 |
|
| - New molecular entities |
|
0 |
0 |
0 |
1 |
|
| - New medicines |
|
1 |
0 |
1 |
5 |
|
| - New generic medicines |
|
9 |
13 |
37 |
29 |
|
| - Others |
|
30 |
12 |
13 |
32 |
|
| Number of active ingredients |
Total |
19 |
22 |
23 |
24 |
30 |
|
Core medicines (A) |
|
19 |
22 |
23 |
24 |
|
|
Exiting medicines (B) |
|
6 |
4 |
8 |
6 |
|
|
New entrants (C) |
|
13 |
8 |
12 |
17 |
|
| - New molecular entities |
|
0 |
0 |
0 |
1 |
|
| - New medicines |
|
1 |
0 |
1 |
5 |
|
| - New generic medicines |
|
6 |
5 |
6 |
5 |
|
| - Others | 6 | 3 | 5 | 6 |
*This table includes only those statins that were prescribed by doctors out of statins on the Korean National Health Insurance benefit list.